FDA — authorised 19 December 2014
- Application: NDA202342
- Marketing authorisation holder: BELCHER
- Indication: Labeling
- Status: approved
FDA authorised Strontium Oxydatum on 19 December 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 19 December 2014; FDA has authorised it.
BELCHER holds the US marketing authorisation.